Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    SPEC.L Net Margin

    As of 2025-07-03, the Net Margin of Inspecs Group PLC (SPEC.L) is -2.3%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    SPEC.L Net Margin - Historical Value
    DateValue
    2024-12-31 -2.3%
    2023-12-31 -0.5%
    2022-12-31 -3.2%
    2021-12-31 -2.2%
    2020-12-31 -18.8%
    2019-12-31 10.5%
    2018-12-31 6.1%
    2017-12-31 -6.7%
    2016-12-31 3.2%
    -
    SPEC.L Net Margin - Peers Comparison
    TickerNameValue
    ALCJ.PACrossject SA-5957.2%
    AMS.LAdvanced Medical Solutions Group PLC4%
    BACTI B.STBactiguard Holding AB-11.4%
    BCART.BRBiocartis Group NV-113.7%
    BMX.WABioMaxima SA1%
    CLTN.SWColtene Holding AG8.2%
    CRAD B.STC Rad AB12%
    CRM.WAPZ Cormay SA-5.7%
    CTEC.LConvaTec Group PLC8.3%
    DOXA.STDoxa AB-11118.1%
    EKF.LEKF Diagnostics Holdings PLC12.4%
    GBT.PAGuerbet SA1.9%
    GENT.OLGentian Diagnostics ASA29.8%
    HEMC.STHemcheck Sweden AB-1129%
    MED.SWMedartis Holding AG1.6%
    ODX.LOmega Diagnostics Group PLC-51.2%
    OSSD.STOssDsign AB-37.1%
    PFM.WAPrivate Rented Sector SA13.6%
    QTNTQuotient Ltd-324.9%
    RVPRetractable Technologies Inc-36%
    SDI.LSDI Group PLC6.4%
    SIENSientra Inc-81%
    TSTL.LTristel PLC15.5%
    VBSN.SWIVF Hartmann Holding AG12.8%
    XTNTXtant Medical Holdings Inc-14%
    XVIVO.STXvivo Perfusion AB20.9%
    YPSN.SWYpsomed Holding AG11.7%
    Tickers added to watchlist